sars-cov-2

Documents about sars-cov-2

• Immune Responses to COVID-19; Isolation of Neutralizing Antibodies for Therapeutics and Vaccine.#329563ClinicalTrials.gov
• Carrageenan Nasal Spray for COVID-19 Prophylaxis#329577ClinicalTrials.gov
• A Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273 Vaccine in Adolescents 12 to <18 Years Old to Prevent COVID-19#329585ClinicalTrials.gov
• A Phase I Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of SARS-CoV-2 Bivalent mRNA Vaccine (LVRNA021)#343699ClinicalTrials.gov
• A Study to Evaluate the Safety and Immunogenicity of Vaccine CVnCoV in Healthy Adults in Germany for COVID-19#366649ClinicalTrials.gov
• The impact of COVID-19 vaccines on reinfection in Vietnam and Indonesia: the role of vaccine technology and dosage#191054Figshare
• Table 1_CORSA study finds spike-specific blunted immune responses in lymphoma patients after SARS-CoV-2 vaccine.docx#202136Figshare
• Cholinergic dysfunction in COVID-19: frantic search and hoping for the best#280247HAL (France)
• Association of IL6 Gene Polymorphisms with COVID-19 Susceptibility and Inflammation in Pregnant Women#280370HAL (France)
• Genetic polymorphisms and expression of SARS-CoV-2 host entry genes associate with COVID-19 severity in an unvaccinated Moroccan cohort#284219HAL (France)
• Expression analysis of DDC, dACE2, and EPO genes in Moroccan COVID-19 patients: links to viral load and demographics#288294HAL (France)
• Reoviridae-derived short trimerization domain for stabilizing homo-trimerization of vaccine immunogens and therapeutic proteins#1449148Figshare

Related topics